Growing community of inventors

Sutton, United Kingdom

Deborah Smithen

Average Co-Inventor Count = 7.96

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Deborah SmithenCaroline Joy Springer (6 patents)Deborah SmithenDan Niculescu-Duvaz (6 patents)Deborah SmithenLeo Leung (6 patents)Deborah SmithenRichard Marais (5 patents)Deborah SmithenHaoran Tang (5 patents)Deborah SmithenMohammed Aljarah (3 patents)Deborah SmithenMichael Brown (3 patents)Deborah SmithenCedric Callens (3 patents)Deborah SmithenNatalie Miller (2 patents)Deborah SmithenAlfonso Zambon (1 patent)Deborah SmithenKiri North (1 patent)Deborah SmithenAlfonso Zambon (1 patent)Deborah SmithenBen Ayers (1 patent)Deborah SmithenDeborah Smithen (6 patents)Caroline Joy SpringerCaroline Joy Springer (41 patents)Dan Niculescu-DuvazDan Niculescu-Duvaz (26 patents)Leo LeungLeo Leung (6 patents)Richard MaraisRichard Marais (26 patents)Haoran TangHaoran Tang (5 patents)Mohammed AljarahMohammed Aljarah (3 patents)Michael BrownMichael Brown (3 patents)Cedric CallensCedric Callens (3 patents)Natalie MillerNatalie Miller (2 patents)Alfonso ZambonAlfonso Zambon (15 patents)Kiri NorthKiri North (6 patents)Alfonso ZambonAlfonso Zambon (1 patent)Ben AyersBen Ayers (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. The Institute of Cancer Research: Royal Cancer Hospital (6 from 51 patents)


6 patents:

1. 12060360 - Lysyl oxidase inhibitors

2. 12018029 - Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitors

3. 11608330 - Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

4. 11325915 - Lysyl oxidase inhibitors

5. 10995088 - Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

6. 10807974 - Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/14/2025
Loading…